loader image
Thursday, October 9, 2025
78.7 F
McAllen
- Advertisement -

Doctors Hospital at Renaissance Awarded Perinatal Certification from The Joint Commission

Translate to Spanish or other 102 languages!

From left to right, Raquel Saenz, MSN, RN, Clinical Coordinator; Denise Garcia, BSN, RN, NICU Clinical Coordinator; Princy Andrews, BSN, RN, CNOR, Women’s Hospital Perioperative Supervisor; Amy Buffamonte BSN, RN, Director of Newborn Nursery; Annabelle Hernandez, RN, Director of L &D Antepartum and Triage; Aida Martinez-Gonzalez MSN, RN, Vice President; Elana Carr BSN, RN, Clinical Coordinator; Esmeralda Luna, MSN, RN, Women’s Services Nursing Educator; Sandra Acevedo, MSN, RN, Surgical Service Line Director; Jeanette Ortega, MSN, RN, Director of Post-Partum, and Alan Esmilla BSN, RN, Director of WHRT and NICU.

Mega Doctor News

- Advertisement -

Edinburg, TX — Doctors Hospital at Renaissance Health System (DHR) announced The Women’s Hospital at Renaissance (WHR) has earned Perinatal Care Certification from The Joint Commission. The certification program recognizes Joint Commission accredited hospitals committed to achieving integrated, coordinated and patient-centered care for mothers and their newborns.

WHR underwent a rigorous onsite review on June 29-30, 2017 to assess its compliance with certification standards for perinatal care. During the review, Joint Commission experts completed an independent evaluation of WHR’s perinatal health services, as well as the following key requirements:

  • Integrated, coordinated patient-centered care that starts with prenatal and continues through postpartum care
  • Early identification of high-risk pregnancies and births
  • Management of mothers’ and newborns’ risks at a level corresponding to the program’s capabilities
  • Available patient education and information about perinatal care services

“Achieving Perinatal Care Certification recognizes an organization’s commitment to healthy mothers and healthy babies,” said Patrick Phelan, executive director, Hospital Business Development, The Joint Commission. “The certification gives providers an unparalleled advantage when it comes to preparing mothers for labor and delivery, while also being able to help them if complications arise.”

- Advertisement -

“We are delighted to receive Perinatal Care Certification from The Joint Commission, the premier health care quality improvement and accrediting body in the nation,” added Aida Gonzalez-Martinez, MSN, RN, Vice President of The Women’s Hospital at Renaissance. “By achieving this certification, we are focused on ongoing quality-improvement processes to improve care for mothers and newborns.”

Established in 2015, Perinatal Care Certification is awarded for a two-year period to Joint Commission-accredited hospitals.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Urology Institute Expands Expertise with Dr. Kayvon Kian

DHR Health, one of the largest physician-owned hospitals in the United States, proudly serving the Rio Grande Valley since 1997, is excited to welcome Dr. Kayvon Kiani to our esteemed team at the DHR Health Urology Institute.

Unidos Contra la Diabetes to Host 2025 Mini-Symposium and Annual Dia-Beat-IT Health Fair, Nov. 5th

Unidos Contra la Diabetes (UCD) has announced that its 2025 Mini-Symposium and Annual Dia-Beat-IT Health Fair is less than a month away. Moises Arjona Jr., MS, CHWI, Collective Impact Director for UCD, reminded community partners and stakeholders of the upcoming event, encouraging participation and support.

DHR Health Breast Cancer Symposium, Oct. 11th 

To support providers in the community, the DHR Health Continuing Medical Education Department will host the Breast Cancer Symposium on Saturday, October 11, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado.

DHR Health Introduces Advanced PSMA-PET Imaging with Illuccix® for Prostate Cancer Care

To support early and accurate detection, DHR Health now offers Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection), a prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging tracer for the detection of prostate cancer.
- Advertisement -
×